These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
301 related items for PubMed ID: 20395894
21. Quantification of L-arginine, asymmetric dimethylarginine and symmetric dimethylarginine in human plasma: a step improvement in precision by stable isotope dilution mass spectrometry. Martens-Lobenhoffer J, Bode-Böger SM. J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Sep 01; 904():140-3. PubMed ID: 22884474 [Abstract] [Full Text] [Related]
25. Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in renal failure patients. Fleck C, Janz A, Schweitzer F, Karge E, Schwertfeger M, Stein G. Kidney Int Suppl; 2001 Feb 01; 78():S14-8. PubMed ID: 11168976 [Abstract] [Full Text] [Related]
31. Nitric oxide dysregulation in patients with heart failure: the association of depressive symptoms with L-arginine, asymmetric dimethylarginine, symmetric dimethylarginine, and isoprostane. Mommersteeg PM, Schoemaker RG, Eisel UL, Garrelds IM, Schalkwijk CG, Kop WJ. Psychosom Med; 2015 Apr 01; 77(3):292-302. PubMed ID: 25790241 [Abstract] [Full Text] [Related]
32. Concentration of dimethyl-L-arginine in the plasma of patients with end-stage renal failure. MacAllister RJ, Rambausek MH, Vallance P, Williams D, Hoffmann KH, Ritz E. Nephrol Dial Transplant; 1996 Dec 01; 11(12):2449-52. PubMed ID: 9017621 [Abstract] [Full Text] [Related]
33. The effect of rosiglitazone on asymmetric dimethylarginine (ADMA) in critically ill patients. Richir MC, Ellger B, Teerlink T, Siroen MP, Visser M, Spreeuwenberg M, Girbes AR, van der Hoven B, van den Berghe G, Wilhelm AJ, de Vries TP, van Leeuwen PA. Pharmacol Res; 2009 Dec 01; 60(6):519-24. PubMed ID: 19559792 [Abstract] [Full Text] [Related]
34. Increased levels of symmetric dimethyl-arginine are associated with all-cause mortality in patients with symptomatic peripheral arterial disease. Staniszewska A, Rajagopalan S, Al-Shaheen A, Thies F, Brittenden J. J Vasc Surg; 2015 May 01; 61(5):1292-8. PubMed ID: 25776186 [Abstract] [Full Text] [Related]
36. Asymmetric Dimethylarginine Predicts Long-Term Outcome in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Vögeli A, Ottiger M, Meier MA, Steuer C, Bernasconi L, Huber A, Christ-Crain M, Henzen C, Hoess C, Thomann R, Zimmerli W, Mueller B, Schuetz P. Lung; 2017 Dec 01; 195(6):717-727. PubMed ID: 28852826 [Abstract] [Full Text] [Related]
37. Metabolites of the Nitric Oxide (NO) Pathway Are Altered and Indicative of Reduced NO and Arginine Bioavailability in Patients with Cardiometabolic Diseases Complicated with Chronic Wounds of Lower Extremities: Targeted Metabolomics Approach (LC-MS/MS). Krzystek-Korpacka M, Wiśniewski J, Fleszar MG, Bednarz-Misa I, Bronowicka-Szydełko A, Gacka M, Masłowski L, Kędzior K, Witkiewicz W, Gamian A. Oxid Med Cell Longev; 2019 Dec 01; 2019():5965721. PubMed ID: 31396302 [Abstract] [Full Text] [Related]
38. Symmetric dimethylarginine predicts all-cause mortality following ischemic stroke. Schulze F, Carter AM, Schwedhelm E, Ajjan R, Maas R, von Holten RA, Atzler D, Grant PJ, Böger RH. Atherosclerosis; 2010 Feb 01; 208(2):518-23. PubMed ID: 19700158 [Abstract] [Full Text] [Related]
39. Assessment of asymmetrical dimethylarginine metabolism in patients with critical illness. Ghashut RA, Blackwell S, Ryan S, Willox L, McMillan DC, Kinsella J, Talwar D. Eur J Clin Invest; 2017 Apr 01; 47(4):279-288. PubMed ID: 27930821 [Abstract] [Full Text] [Related]
40. Nitric Oxide-Related Biological Pathways in Patients with Major Depression. Baranyi A, Amouzadeh-Ghadikolai O, Rothenhäusler HB, Theokas S, Robier C, Baranyi M, Koppitz M, Reicht G, Hlade P, Meinitzer A. PLoS One; 2015 Apr 01; 10(11):e0143397. PubMed ID: 26581044 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]